_edited.png)
RISK CONCERN
Investment Strategy, Risk Analysis, and Insights by Chartered Professionals
Azenta, Inc. (XNAS:AZTA) In-Depth Stock/Fundamental/Options Analysis Today
Primary Facts
AZTA
Name:
Azenta, Inc. (XNAS:AZTA)
Sector:
- 2791.00K
Industry:
Medical Instruments & Supplies
CEO:
Total Employees:
2,900
Our Technological Advancement Rating
Our Rating:
D
Technological advancement compared to industry is -6214.73% lower
ANALYSIS OF ALL CRITICAL FACTORS & RISKS RELATED TO THE STOCK & FUNDAMENTAL/LONG-TERM ANALYSIS OF AZENTA, INC.(AZTA) AS PER DATA ANALYSIS OF LAST 3 YEARS AND COMPARISON WITH COMPETITORS/PEERS, AND MEDICAL INSTRUMENTS & SUPPLIES INDUSTRY. DATE: 07/09/2022
Primary Targets/Price Insights
Previous Close ($) :
50.81
One Month Price Target:
$51.25
Six Month Price Target :
$53.44
Likely Price in One Year's Time:
Ticker:
$56.07
Likely Trading Range Today Under (Normal Volatility)
$50.55
Price Upper limit ($) :
$51.16
Price Lower limit ($) :
Crash Risk Prep/Key Price Levels (High Volatility/Risk)
Price, as per data analysis, isn't likely to fall below:
Today:
$47.17
This week:
$42.68
This month :
$34.55
Other Primary facts
Market Cap:
3.78B
Market Cap Classification:
Mid Cap
Number of Shares
IPO Date:
75.02M
Best/Worst Daily Performance (Last 3+ Years)
Highest Daily Appreciation:
17.77%
-16.71%
Worst Daily Decline:
Our Options Trading Entry Points
Iron Condor entry points for options expiring in 1 week's time
Low risk (<2%) entry points
Buy Call:
Sell Call:
Buy Put:
Sell Put:
$67.68
$59.91
$33.94
$41.71
Medium risk (<10%) entry points
Buy Call
Sell Call
$57.38
Buy Put:
Sell Put:
$55.72
$44.22
$45.90
These entry points can be used for other strategies, such as butterflies, straddles, etc.
Risk-Adjusted returns (Sharpe Ratio) of
AZTA
Sharpe Ratio:
2.33%
Comparison:
AZTA, is amongst the top 40% stocks with highest risk-adjusted returns
Sharpe ratio is 45.68% higher than the industry
& ratio is 2.34% higher than the market/S&P 500 average
Average Returns/Yield of
AZTA
Daily returns:
0.09%
Weekly returns:
0.46%
Monthly returns:
1.82%
Yearly returns:
14.68%
Comparison of returns:
Average annual returns/yield (last 3 years) is 49.01% above industry average
Classification:
AZTA, is amongst the top 40% highest yielding stocks in terms of daily returns
Results of T-Test of Returns:
0.89
Statistical test of Returns:
AZTA has not yielded statistically significant higher returns when compared to the market
Volatility (measured by Standard Deviation)
Daily Volatility:
3.53%
Weekly Volatility:
7.89%
Monthly Volatility:
15.78%
Yearly Volatility:
54.67%
Volitlilty of last five days (Measured by Standard Deviation)
Average Volatility of this Week:
0.40%
Volatility in last five trading days has been -88.58% below long-term volatility
Value at Risk Analysis (VaR)
Daily VaR:
-7.16%
Weekly VaR:
-16.00%
Monthly VaR:
-32.00%
How Much Can the price of
AZTA
Decline in a Recession?
Likely price decline in a recession:
Base case (decline):
-27%
Worst case (decline):
>85%
This translates to price declining to:
$36.96
This translates to price declining to:
$7.62
Severe Crash Probability
Risk of crash in next 6/12 months: High (50-70%)
What is Value at Risk (VaR)?
Risk Fundamentals
AZTA is a 125.88% riskier investment compared to the market/S&P 500 & is 93.51% riskier than Nasdaq (IXIC)
Risk (measured by volatility) is 21.55% above industry average
Overall, it is amongst the top 50% most risky stocks
Beta Examination of
AZTA
Beta in relation to market/S&P 500--1.54
Expected beta in 1 year's time:
1.079
Expected beta in 3 year's time:
1.525
Unlevered (debt free) Beta:
1.439
Beta in relation to Nasdaq (XNAS):
1.345
Beta in relation to all global stocks::
0.9
Beta Comparison & Analysis
Beta of competitors/peers::
-
-
Average Industry Beta:
0.989
Beta is 55.69% above industry average
Sustainable Growth Rate Analysis
Sustainable growth rate for this stock/firm:
4.18%
Sustainable growth rate is -71.58% below industry average
Alpha provided | Alpha Analysis
Alpha provided:
0.082
Alpha is 71.94% above industry average alpha yield
Alpha is 521% higher than market/& is unsustainably high
Analysis of Cost of Capital of
AZTA
Equity cost of capital:
0.137
Equity cost of capital is 38.02% above industry mean WACC
Unlevered (without debt) cost of capital:
12.80%
Before-tax cost of debt:
5.20%
After-tax cost of debt:
4.11%
Overall debt rating:
Lower BB medium grade (Fifth highest grade)
Weighted average cost of capital (WACC):
4.11%
WACC is 54.12% above industry mean WACC
Key Per-Share Metrics & Analysis
Revenue per share:
$1.64
Revenue growth rate per share of (3Y):
2.79
Annual revenue growth rate is -144.62% below industry average
EPS:
$29.68
Expected Annual growth rate of EPS (3Y):
-34.35%
Expected future EPS growth rate is -397.07% lower than the Medical Instruments & Supplies industry
Free cash flow (FCF) per share:
-
Balance sheet equity growth per share: -0.20%
Equity growth rate per share is -177.47% lower than the industry
Debt per share
$1.83
EBITDA per share
$29.22
Valuation Analysis Today of
AZTA
P/E Ratio:
267.79
P/E Ratio of Competitors/Peers:
-
- & is 436.77% higher than the industry
Stock price/value with industry average P/E ratio: $1,480.73
AZTA is -96.57% undervalued if valued using industry average P/E ratio
Share value as per dividend discount (DDM) model: $195.83
Present value of the expected future dividends only: $2.92
P/S (Price to Sales ratio):
30.95
Price to sales ratio is 317.35% above the industry mean
P/B (Price to book value ratio):
2.79
-
Price to free cash flow ratio is 45.64% higher than the industry
Net income growth rate (3Y):
-9.79%
Net income growth rate is -90.74% lower than the industry average net income growth rate
Dividend Analysis
Dividend payout rate: 0.34%
Dividend yeild: 0.79%
Previous Dividend: $0.10
Previous adjusted dividend: $0.10
Previous Dividend: $0.40
-
-
Average dividend payment (long-term): $0.10
Average dividend increase/decrease (growth rate) % per period: 0.00%
Expected next dividend payment date: 23/03/2022
Expected next dividend record date: 03/03/2022
Expected next dividend declaration date: 02/08/2022
Previous dividend payment date: 23/12/2021
Previous dividend record date: 12/03/2021
Previous dividend declaration date: 11/10/2021
Dividend History:
2021-12-02--$0.10
2021-06-03--$0.10
2020-12-03--$0.10
2021-09-02--$0.10
2021-03-04--$0.10
2020-09-03--$0.10
-
In-depth Debt & Leverage Analysis
Debt to equity ratio:
10.04%
Net debt to equity ratio:
-12.10%
Debt to assets ratio:
7.40%
Net debt to assets ratio:
-8.92%
Debt-to-asset ratio is -79.38% below industry average
Ability to repay debt:
Interest coverage ratio:
848.21
Interest coverage ratio is 1095.75% more than industry average
Looking forward:
Debt growth rate:
15.19%
Annual debt growth is -86% lower than industry average debt growth rate
Debt repayment rate in last quarter: 0.14%
Analysis of Key Statistics
Correlation of price movement with the market:
0.644
Statistical significance of correlation:
AZTA has a statistically significant correlation with the market
Average Correlation of the industry with the market:
0.505
Stock price is 27.59% more correlated with the market, compared to the industry average correlation
R Squared (percentage of price movement explained by movement of the market):
0.505
Correlation of price movement with Nasdaq (^IXIC):
-0.026
Covariance of price movement with the market:
-0.052
Kurtosis
3.395
Returns are, approximately, normally distributed (mesokurtic)
Skewness of returns:
0.104
Returns are, approximately, symmetrical
Fundamental Analysis & Dupont Analysis of
AZTA
Gross Profit Margin Ratio:
101%
Operating Profit Margin Ratio:
-79.21%
Operating profit margin is -691.77% lower than the industry
Net Profit Margin Ratio:
101%
Effective Tax Rate:
29.61%
Effective tax rate is -9.91% lower than the industry
Dupont Method
Net Profit Margin
Return on Equity Ratio (ROE):
×
ROA
=
×
159.19%
Return on equity (ROE) is -449.14% lower than the industry
Financial Leverage
Asset Turnover Ratio (ROA):
117.35%
Return on assets (ROA) is 1538.54% higher than the industry
Financial Leverage:
1.1x
Current Ratio:
2.33
Current ratio is -36.16% below industry average
Cash Conversion Cycle (days):
93.2
Cash conversion cycle is 76.83% above industry average
The remaining useful life of property plant & equipment is: 0.4 years
Stock based compensation to net income ratio:
0.36%
In-depth Efficiency Analysis
Revenue generated per employee:
42.5K
Each employee generates -88% less revenue than industry average revenue per employee
EBITDA generated per employee:
755.8K
Each employee generates 579% more EBITDA than industry average revenue per employee
Profit generated per employee:
750.6K
Each employee generates 866% more net income/profit than industry average revenue per employee
Free cash flow (FCF) generated per employee:
- 1.0K
Each employee generates -83% less free cash flow than industry average revenue per employee
Assets/Capital per employee
364.9K
Each employee generates -83% less free cash flow than industry average revenue per employee
Research & Development (R&D) Analysis
Research & development (R&D) investment growth rate-- -62.05%
Growth rate in R&D investment/expenditure is -24066.19% lower than the industry
Competitors/Peer firms of
AZTA
-
-
-
-
-
-
-
-
-
Current Analyst Ratings
Strong buy�0%
Buy�0%
Hold�0%
Sell�0%
Strong sell�0%
Overall analyst sentiment is: -
Income Statement
Period:
TTM
Date:
3/31/22
Revenue:
123.16M
Cost of Revenue:
Gross Profit:
R&D Expense
General & Admin Expenses:
Selling, General & Admin Expenses
Sales and Marketing Expenses
Other Expenses :
Operating Expenses :
Cost & Expenses :
Interest Income:
Interest Expenses:
Depreciation & Amortization:
EBITDA:
Operating Income:
Other Income Expenses:
Income Before Tax:
Income Tax Expense:
Net Income:
Balance Sheet
Date:
Calendar Year:
Period:
Cash & Cash Equivalents:
Short Term Investments:
Cash & Short Term Investments:
Net Receivables:
Inventory:
Other Current Assets:
Total Current Assets:
PP&E:
Goodwill:
Intangible Assets:
Long Term Investments:
Tax Assets:
Other Non-Current Assets:
Total Non-Current Assets:
Other Assets:
Total Assets:
Accounts Payable:
Short Term Debt:
Tax Payables:
Deferred Revenue:
Other Current Liabilities:
Total Current Liabilities:
Long Term Debt:
Other Non-Current Liabilities:
Total Non Current Liabilities:
Other Liabilities:
Total Liabilities:
Common Stock:
Retained Earnings:
Accumulated Other Comprehensive Loss:
Other Total Stockholders' Equity:
Total Stockholders' Equity:
Total Liabilities and Stockholders' Equity:
Total Investments:
Total Debt:
Net Debt:
48.92M
74.23M
- 3717.99K
-
235.56M
-
- 60710.94K
171.14M
3.61M
2.58M
46.67M
2.19B
- 97556.00K
2.18B
- 115956.00K
- 34331.00K
2.18B
Statement of Cash Flow
Date:
Period:
12.88M
Differed Income Tax :
- 3084.00K
Stock Based Compensation :
7.89M
Change in Working Capital :
- 45353.00K
Accounts Receivables:
1.12M
Other Working Capital:
- 1315.00K
Other Non-Cash Items:
43.28M
Net Cash Provided by Operating Activities:
15.62M
Investments in PP&E:
- 18409.00K
Net Acquisitions:
-
Purchases of Investments:
- 46.00K
Sales/Maturities of Investments:
Other Investing Activities:
Net Cash Used for Investing Activities:
Debt Repayment:
Common Stock Issued:
Common Stock Repurchased:
Dividend Paid:
Other Financing Activities:
Net Cash Used Provided by Financing Activities:
Effect of FOREX on Changes in Cash:
Net Changes in Cash:
Cash at End of Period:
Cash at Beginning of Period:
Operating Cash Flow:
Capital Expenditure:
Free Cash Flow (FCF):
12/31/21
2022
Q1
215.17M
51.00K
215.22M
126.00M
70.14M
385.37M
796.73M
147.26M
468.59M
178.59M
3.72M
13.85M
246.20M
1.06B
-
1.85B
46.87M
-
14.04M
28.48M
266.45M
341.80M
137.31M
- 4733.00K
145.71M
-
487.51M
884.00K
- 434225.00K
24.1M
1.78B
December 31, 2021 at 12:00:00 AM
220.27M
1.37B
1.85B
3.78M
49.70M
- 165466.0K
30.00K
-
- 18425.00K
- 186.00K
-
-
- 7494.00K
-
- 7680.00K
- 1804.00K
- 12291.00K
273.04M
285.33M
15.62M
- 18409.00K
- 2791.00K
Our Proprietary Portfolio Rating
Our Rating:
D
Price Forecast/Expected Price in Next 5 Years of
AZTA
2023
2024
2025
2026
2027
$56.35
$1,481.96
$1,635.35
$1,804.63
$1,991.42